{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Antibiotic resistance", "E. coli", "Intensive care", "Ozone", "Porcine sepsis model"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35467176", "DateRevised": {"Year": "2022", "Month": "08", "Day": "29"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "04", "Day": "25"}], "ELocationID": ["14", "10.1186/s40635-022-00443-w"], "Journal": {"ISSN": "2197-425X", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "25"}}, "Title": "Intensive care medicine experimental", "ISOAbbreviation": "Intensive Care Med Exp"}, "ArticleTitle": "Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis.", "Pagination": {"StartPage": "14", "MedlinePgn": "14"}, "Abstract": {"AbstractText": ["Sepsis is associated with substantial mortality rates. Antibiotic treatment is crucial, but global antibiotic resistance is now classified as one of the top ten global public health risks facing humanity. Ozone (O<sub>3</sub>) is an inorganic molecule with no evident function in the body. We investigated the bactericide properties of ozone, using a novel system of extracorporeal ozone blood treatment. We hypothesized that ozone would decrease the concentration of viable Escherichia coli (E. coli) in human whole blood and that the system would be technically feasible and physiologically tolerable in a clinically relevant model of E. coli sepsis in swine.", "The E. coli strain B09-11822, a clinical isolate from a patient with septic shock was used. The in vitro study treated E. coli infected human whole blood (n\u2009=\u20096) with ozone. The in vivo 3.5-h sepsis model randomized swine to E. coli infusion and ozone treatment (n\u2009=\u20095) or E. coli infusion and no ozone treatment (n\u2009=\u20095). Live E. coli, 5\u2009\u00d7\u200910<sup>7</sup> colony-forming units (CFU/mL) was infused in a peripheral vein. Ozone treatment was initiated with a duration of 30\u00a0min after 1.5\u00a0h.", "The single pass in vitro treatment decreased E. coli by 27%, mean 1941 to 1422\u00a0CFU/mL, mean of differences -\u2009519.0 (95% CI -\u2009955.0 to -\u200982.98, P\u2009=\u20090.0281). pO<sub>2</sub> increased (95% CI 31.35 to 48.80, P\u2009=\u20090.0007), pCO<sub>2</sub> decreased (95% CI -\u20093.203 to -\u20091.134, P\u2009=\u20090.0069), oxyhemoglobin increased (95% CI 1.010 to 3.669, P\u2009=\u20090.0113). Methemoglobin was not affected. In the sepsis model, 9/10 swine survived. One swine randomized to ozone treatment died from septic shock before initiation of the treatment. Circulatory, respiratory, and metabolic parameters were not affected by the ozone treatment. E. coli in arterial blood, in organs and in aerobic and anaerobic blood cultures did not differ. Hemoglobin, leucocytes, and methemoglobin were not affected by the treatment.", "Ozone decreased the concentration of viable E. coli in human whole blood. The system was technically feasible and physiologically tolerable in porcine sepsis/septic shock and should be considered for further studies towards clinical applications."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden."}], "LastName": "Skorup", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section for Experimental Traumatology, Department of Neuroscience, Karolinska Institutet, Biomedicum - 8B, 171 77, Stockholm, Sweden."}], "LastName": "Fransson", "ForeName": "Anette", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section for Experimental Traumatology, Department of Neuroscience, Karolinska Institutet, Biomedicum - 8B, 171 77, Stockholm, Sweden."}], "LastName": "Gustavsson", "ForeName": "Jenny", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sangair AB, Stockholm, Sweden."}], "LastName": "Sj\u00f6holm", "ForeName": "Johan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sangair AB, Stockholm, Sweden."}], "LastName": "Rundgren", "ForeName": "Henrik", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden."}, {"Identifier": [], "Affiliation": "Department of Clinical Microbiology, Karolinska University Hospital, Huddinge, Sweden."}], "LastName": "\u00d6zenci", "ForeName": "Volkan", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden."}], "LastName": "Wong", "ForeName": "Alicia Y W", "Initials": "AYW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Science at Education S\u00f6dersjukhuset, Unit of Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden."}], "LastName": "Karlsson", "ForeName": "Tomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Science at Education S\u00f6dersjukhuset, Unit of Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden."}], "LastName": "Svens\u00e9n", "ForeName": "Christer", "Initials": "C"}, {"Identifier": ["0000-0003-2372-6114"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section for Experimental Traumatology, Department of Neuroscience, Karolinska Institutet, Biomedicum - 8B, 171 77, Stockholm, Sweden. mattias.gunther@ki.se."}, {"Identifier": [], "Affiliation": "Department of Clinical Science at Education S\u00f6dersjukhuset, Unit of Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden. mattias.gunther@ki.se."}], "LastName": "G\u00fcnther", "ForeName": "Mattias", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Intensive Care Med Exp", "NlmUniqueID": "101645149", "ISSNLinking": "2197-425X"}, "CoiStatement": "J.S. and H.R. are owners of/employed by Sangair AB. All other authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u2013377. doi: 10.1007/s00134-017-4683-6.", "ArticleIdList": ["10.1007/s00134-017-4683-6", "28101605"]}, {"Citation": "Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222\u2013231. doi: 10.1007/s00134-009-1738-3.", "ArticleIdList": ["10.1007/s00134-009-1738-3", "PMC2826633", "20069275"]}, {"Citation": "World Health Organization . Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014."}, {"Citation": "World Health Organization . Newsroom antimicrobial resistance; 13 October 2020. Geneva: World Health Organization; 2020."}, {"Citation": "Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MKF, Baloch Z. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645\u20131658. doi: 10.2147/idr.s173867.", "ArticleIdList": ["10.2147/idr.s173867", "PMC6188119", "30349322"]}, {"Citation": "Bocci V, Zanardi I, Travagli V. Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Med Gas Res. 2011;1(1):6. doi: 10.1186/2045-9912-1-6.", "ArticleIdList": ["10.1186/2045-9912-1-6", "PMC3231820", "22146387"]}, {"Citation": "Wentworth P, Jr, Nieva J, Takeuchi C, Galve R, Wentworth AD, Dilley RB, DeLaria GA, Saven A, Babior BM, Janda KD, Eschenmoser A, Lerner RA. Evidence for ozone formation in human atherosclerotic arteries. Science. 2003;302(5647):1053\u20131056. doi: 10.1126/science.1089525.", "ArticleIdList": ["10.1126/science.1089525", "14605372"]}, {"Citation": "Jerrett M, Burnett RT, Pope CA, 3rd, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M. Long-term ozone exposure and mortality. N Engl J Med. 2009;360(11):1085\u20131095. doi: 10.1056/NEJMoa0803894.", "ArticleIdList": ["10.1056/NEJMoa0803894", "PMC4105969", "19279340"]}, {"Citation": "Bocci V. The clinical application of ozonetherapy. In: Bocci V, editor. OZONE: a new medical drug. Dordrecht: Springer; 2011. pp. 97\u2013232."}, {"Citation": "Bialoszewski D, Pietruczuk-Padzik A, Kalicinska A, Bocian E, Czajkowska M, Bukowska B, Tyski S. Activity of ozonated water and ozone against Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Med Sci Monit. 2011;17(11):Br339\u2013Br344. doi: 10.12659/msm.882044.", "ArticleIdList": ["10.12659/msm.882044", "PMC3539485", "22037737"]}, {"Citation": "Burgassi S, Zanardi I, Travagli V, Montomoli E, Bocci V. How much ozone bactericidal activity is compromised by plasma components? J Appl Microbiol. 2009;106(5):1715\u20131721. doi: 10.1111/j.1365-2672.2008.04141.x.", "ArticleIdList": ["10.1111/j.1365-2672.2008.04141.x", "19226394"]}, {"Citation": "Varga L, Szigeti J. Use of ozone in the dairy industry: a review. Int J Dairy Technol. 2016;69(2):157\u2013168. doi: 10.1111/1471-0307.12302.", "ArticleIdList": ["10.1111/1471-0307.12302"]}, {"Citation": "Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014;27(4):647\u2013664. doi: 10.1128/cmr.00002-14.", "ArticleIdList": ["10.1128/cmr.00002-14", "PMC4187633", "25278570"]}, {"Citation": "Skorup P, Maudsdotter L, Lipcsey M, Castegren M, Larsson A, Jonsson AB, Sj\u00f6lin J. Beneficial antimicrobial effect of the addition of an aminoglycoside to a \u03b2-lactam antibiotic in an E. coli porcine intensive care severe sepsis model. PLoS ONE. 2014;9(2):e90441. doi: 10.1371/journal.pone.0090441.", "ArticleIdList": ["10.1371/journal.pone.0090441", "PMC3938751", "24587365"]}, {"Citation": "Battino R, Rettich TR, Tominaga T. The solubility of oxygen and ozone in liquids. J Phys Chem Ref Data. 1983;12(2):163\u2013178. doi: 10.1063/1.555680.", "ArticleIdList": ["10.1063/1.555680"]}, {"Citation": "Ani C, Farshidpanah S, Bellinghausen Stewart A, Nguyen HB. Variations in organism-specific severe sepsis mortality in the United States: 1999\u20132008. Crit Care Med. 2015;43(1):65\u201377. doi: 10.1097/CCM.0000000000000555.", "ArticleIdList": ["10.1097/CCM.0000000000000555", "25230374"]}, {"Citation": "Blandy O, Honeyford K, Gharbi M, Thomas A, Ramzan F, Ellington MJ, Hope R, Holmes A, Johnson AP, Aylin P. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011\u20132015 data from west London. J Hosp Infect. 2019;101(2):120\u2013128. doi: 10.1016/j.jhin.2018.10.024.", "ArticleIdList": ["10.1016/j.jhin.2018.10.024", "30403958"]}, {"Citation": "Umemura Y, Ogura H, Takuma K, Fujishima S, Abe T, Kushimoto S, Hifumi T, Hagiwara A, Shiraishi A, Otomo Y. Current spectrum of causative pathogens in sepsis: a prospective nationwide cohort study in Japan. Int J Infect Dis. 2021;103:343\u2013351. doi: 10.1016/j.ijid.2020.11.168.", "ArticleIdList": ["10.1016/j.ijid.2020.11.168", "33221519"]}, {"Citation": "Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8(1):26\u201338. doi: 10.1038/nrmicro2265.", "ArticleIdList": ["10.1038/nrmicro2265", "19966814"]}, {"Citation": "Hobman JL, Penn CW, Pallen MJ. Laboratory strains of Escherichia coli: model citizens or deceitful delinquents growing old disgracefully? Mol Microbiol. 2007;64(4):881\u2013885. doi: 10.1111/j.1365-2958.2007.05710.x.", "ArticleIdList": ["10.1111/j.1365-2958.2007.05710.x", "17501914"]}, {"Citation": "Vincent J-L, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23(1):1\u201311. doi: 10.1186/s13054-018-2293-5.", "ArticleIdList": ["10.1186/s13054-018-2293-5", "PMC6545004", "31151462"]}, {"Citation": "Skorup P, Maudsdotter L, Tano E, Lipcsey M, Castegren M, Larsson A, Sj\u00f6lin J. Dynamics of endotoxin, inflammatory variables, and organ dysfunction after treatment with antibiotics in an Escherichia coli porcine intensive care sepsis model. Crit Care Med. 2018;46(7):e634\u2013e641. doi: 10.1097/ccm.0000000000003139.", "ArticleIdList": ["10.1097/ccm.0000000000003139", "29595561"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29(4):646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Volkhovskaya NB, Tkachenko SB, Belopolsky AA. Modulation of phagocytic activity of blood polynuclear leukocytes with ozonized physiological saline. Bull Exp Biol Med. 2008;146(5):559\u2013561. doi: 10.1007/s10517-009-0340-6.", "ArticleIdList": ["10.1007/s10517-009-0340-6", "19526090"]}, {"Citation": "Mendiratta S, Qu ZC, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med. 1998;24(5):789\u2013797. doi: 10.1016/s0891-5849(97)00351-1.", "ArticleIdList": ["10.1016/s0891-5849(97)00351-1", "9586809"]}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose\u2013response relationship. J Transl Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006;216(3):493\u2013504. doi: 10.1016/j.taap.2006.06.009.", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Travagli V, Zanardi I, Bernini P, Nepi S, Tenori L, Bocci V. Effects of ozone blood treatment on the metabolite profile of human blood. Int J Toxicol. 2010;29(2):165\u2013174. doi: 10.1177/1091581809360069.", "ArticleIdList": ["10.1177/1091581809360069", "20335512"]}, {"Citation": "Hare GM, Tsui AK, Crawford JH, Patel RP. Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress\u2014the example of anemia? Redox Biol. 2013;1(1):65\u201369. doi: 10.1016/j.redox.2012.12.003.", "ArticleIdList": ["10.1016/j.redox.2012.12.003", "PMC3757671", "24024138"]}, {"Citation": "Halliwell B. The wanderings of a free radical. Free Radic Biol Med. 2009;46(5):531\u2013542. doi: 10.1016/j.freeradbiomed.2008.11.008.", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.11.008", "19111608"]}, {"Citation": "Foksinski M, Bialkowski K, Skiba M, Ponikowska I, Szmurlo W, Olinski R. Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients. Mutat Res. 1999;438(1):23\u201327. doi: 10.1016/s1383-5718(98)00155-7.", "ArticleIdList": ["10.1016/s1383-5718(98)00155-7", "9858672"]}, {"Citation": "Mair K, Sedlak C, K\u00e4ser T, Pasternak A, Levast B, Gerner W, Saalm\u00fcller A, Summerfield A, Gerdts V, Wilson H. The porcine innate immune system: an update. Dev Comp Immunol. 2014;45(2):321\u2013343. doi: 10.1016/j.dci.2014.03.022.", "ArticleIdList": ["10.1016/j.dci.2014.03.022", "PMC7103209", "24709051"]}, {"Citation": "Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol. 2012;20(1):50\u201357. doi: 10.1016/j.tim.2011.11.002.", "ArticleIdList": ["10.1016/j.tim.2011.11.002", "PMC7173122", "22153753"]}, {"Citation": "Swindle MM, Makin A, Herron AJ, Clubb FJ, Jr, Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol. 2012;49(2):344\u2013356. doi: 10.1177/0300985811402846.", "ArticleIdList": ["10.1177/0300985811402846", "21441112"]}, {"Citation": "Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock. 2008;30(7):53\u201359. doi: 10.1097/SHK.0b013e318181a343.", "ArticleIdList": ["10.1097/SHK.0b013e318181a343", "18704008"]}, {"Citation": "Monard C, Rimmel\u00e9 T, Ronco C. Extracorporeal blood purification therapies for sepsis. Blood Purif. 2019 doi: 10.1159/000499520.", "ArticleIdList": ["10.1159/000499520", "30974444"]}, {"Citation": "Tenga N, Giordano RS, Greco R, Panetta V, Piazza L, Belloni L. OP03-4\u2014effects of early use of LPS adsorption filter in acute aortic dissection type A: preliminary results. J Cardiothorac Vasc Anesth. 2018;32:S34\u2013S35. doi: 10.1053/j.jvca.2018.08.079.", "ArticleIdList": ["10.1053/j.jvca.2018.08.079"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "17"}, {"Year": "2022", "Month": "4", "Day": "9"}, {"Year": "2022", "Month": "4", "Day": "25", "Hour": "12", "Minute": "6"}, {"Year": "2022", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["35467176", "PMC9038973", "10.1186/s40635-022-00443-w", "10.1186/s40635-022-00443-w"]}}], "PubmedBookArticle": []}